Frontiers in Immunology | Vaccines and Molecular Therapeutics

Systematic Review

Published on 25 Sep 2025

Efficacy of different allergen-specific immunotherapies for the treatment of allergic rhinitis in children and adults: an umbrella review

in Vaccines and Molecular Therapeutics

Yu He
Xinghong Liu
Bin Zhou
Tianrong Dai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1658826

1,133 views

Review

Accepted on 23 Sep 2025

Insights into tumor vaccines for elderly individuals in the context of immunosenescence

in Vaccines and Molecular Therapeutics

Chenglong Li
Zhujun Chen
Changyu Zhu
Min Chen
Jinqi Li
Lei Zhong
Yingying Hou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1660874

426 views

Original Research

Published on 23 Sep 2025

Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses

in Vaccines and Molecular Therapeutics

Wilbert Mbuya
Augusta Horvath
Kathrin Held
Lucas Maganga
Michael Hoelscher
Linda-Gail Bekker
Ann Duerr
Zoe Moodie
Gavin Churchyard
Michael C. Keefer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601865

879 views

Original Research

Published on 23 Sep 2025

Comparative analysis of neutralization assays performed using live SARS-CoV-2 virus and pseudovirus to assess immunogenicity of a bivalent SARS-CoV-2 protein vaccine in humans

in Vaccines and Molecular Therapeutics

Cuige Gao
Jiang Yi
Adam Baidoo
Dongfang Liu
Jing Li
Dongyang Li
Jian Li
Qiang Zhou
Liangzhi Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1650083

550 views

Original Research

Published on 22 Sep 2025

Humoral response induced after intranasal vaccination with heat inactivated Acinetobacter baumannii protects immunodeficient mice against hypervirulent LAC-4 strain

in Vaccines and Molecular Therapeutics

Thomas Rouma
Emeline Barbieux
Lorenzo Bossi
Katy Poncin
Sébastien Denanglaire
Yohannes Tafesse
David Vermijlen
Sandrine Delbauve
Véronique Flamand
Juliette Van Buylaere

Frontiers in Immunology

doi 10.3389/fimmu.2025.1641997

795 views

Original Research

Published on 22 Sep 2025

Preclinical in vivo evaluation of a gonococcal multivalent vaccine containing antigens identified by CASS

in Vaccines and Molecular Therapeutics

Shea K. Roe
Bo Zheng
Sunita Gulati
Caroline Genco
Sanjay Ram
Paola Massari

Frontiers in Immunology

doi 10.3389/fimmu.2025.1688536

669 views

Review

Published on 19 Sep 2025

Decadal advances and future prospects in subunit vaccine development against Streptococcus suis infection

in Vaccines and Molecular Therapeutics

Lihua Fang
Jie Ning

Frontiers in Immunology

doi 10.3389/fimmu.2025.1680732

882 views

Original Research

Published on 19 Sep 2025

Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2

in Vaccines and Molecular Therapeutics

Allyson H. Hirsch
Calder R. Ellsworth
William A. Lewis
Ryan Craig
Amy E. Meyer
Jonatan Maldonado
Frania Ramirez Lopez
Syamala Rani Thimmiraju
James B. McLachlan
Xuebin Qin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1673460

1,391 views

Original Research

Published on 19 Sep 2025

A nanodiamond-formulated plant protein induces robust immunity against porcine epidemic diarrhea virus in piglets

in Vaccines and Molecular Therapeutics

Thuong Thi Ho
Hoai Thu Tran
Phuong Minh Thi Nguyen
Huyen Thi Bui
Hien Thu Thi Nguyen
Thao Bich Thi Le
Minh Dinh Pham
Wesley Wei-Wen Hsiao
Dai Huu Nguyen
Ha Hoang Chu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1674222

799 views

Correction

Published on 19 Sep 2025

Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis

in Vaccines and Molecular Therapeutics

Clara Sánchez-Menéndez
Alejandro Zurdo
Magdalena Corona
Elena Mateos de la Morenas
Sara Rodríguez-Mora
Guiomar Casado
Javier García-Pérez
Mayte Pérez-Olmeda
Susana Domínguez
María Aránzazu Murciano-Antón

Frontiers in Immunology

doi 10.3389/fimmu.2025.1706723

849 views

Original Research

Accepted on 18 Sep 2025

A biomimetic model composed of injectable 3D-muscle like tissue, stromal and immune cells for recapitulating the rapid immune signature predictive of mRNA vaccine immunogenicity

in Vaccines and Molecular Therapeutics

Marilena Paola Etna
Claudia Fuoco
Martina Severa
Daniela Ricci
Alessandro Sinigaglia
Camilla Lucca
Giada Cairo
Barbara Bottazzi
Cecilia Garlanda
Anna Teresa Palamara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1651095

230 views

Original Research

Published on 18 Sep 2025

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice

in Vaccines and Molecular Therapeutics

Alena Reguzova
Verena Haug
Carina Metz
Melanie Müller
Madeleine Fandrich
Alex Dulovic
Ralf Amann

Frontiers in Immunology

doi 10.3389/fimmu.2025.1675859

976 views

Review

Published on 18 Sep 2025

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons

in Vaccines and Molecular Therapeutics

Rodney Ogwang
Mohamed Adan
Philip Bejon
Melissa C. Kapulu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1672945

1,160 views

Original Research

Accepted on 17 Sep 2025

Immunoadjuvanted influenza vaccine immunogenicity in children with type 1 diabetes over two consecutive seasons

in Vaccines and Molecular Therapeutics

Mikhail Petrovich Kostinov
Maria Alexandrovna Kvasova
Alla Anatolievna Tarasova
Anna Vlasenko
Elena Vladimirovna Kolbasina
Darya Alexandrovna Bydanova
ARISTITSA KOSTINOVA
Valentina Polishchuk
Isabella Abramovna Khrapunova
Marina Loktionova

Frontiers in Immunology

doi 10.3389/fimmu.2025.1597619

387 views

Review

Accepted on 16 Sep 2025

MAPPs Assays For Non-Clinical Immunogenicity Risk Assessment: Best Practices Recommended By The European Immunogenicity Platform

in Vaccines and Molecular Therapeutics

Anette Christine Karle
Katharina L. Kopp
Robert Joseph Seward
Sophie Tourdot
Chloé Ackaert
Michael Gutknecht
Edward Cloake
Noel Smith
Axel Ducret

Frontiers in Immunology

doi 10.3389/fimmu.2025.1690101

397 views

Original Research

Accepted on 16 Sep 2025

Development of potent HLA-A*02:01-restricted peptide-based cytotoxic T-Cells against SARS-CoV-2 infections in kidney patients

in Vaccines and Molecular Therapeutics

Chih-Chao Chang
Ya Nan Liu
ZHENG XU
Elena-Rodica Vasilescu
Ping Li
Eric K Ho
Muyang Li
Syed A Husain
Govind Bhagat
Sumit Mohan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1664371

450 views